Literature DB >> 21939454

Aldolase mRNA expression in endometrial cancer and the role of clotrimazole in endometrial cancer cell viability and morphology.

Paulette Mhawech-Fauceglia, Dan Wang, Joshua Kesterson, Amy Beck, Karen L de Mesy Bentley, Stuti Shroff, Susanna Syriac, Peter Frederick, Song Liu, Kunle Odunsi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939454      PMCID: PMC5047381          DOI: 10.1111/j.1365-2559.2011.03944.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  10 in total

1.  Glycolytic enzyme interactions with tubulin and microtubules.

Authors:  J L Walsh; T J Keith; H R Knull
Journal:  Biochim Biophys Acta       Date:  1989-11-09

Review 2.  Glucose metabolism and cancer.

Authors:  Reuben J Shaw
Journal:  Curr Opin Cell Biol       Date:  2006-10-12       Impact factor: 8.382

3.  Interaction of muscle glycolytic enzymes with thin filament proteins.

Authors:  W W Bronstein; H R Knull
Journal:  Can J Biochem       Date:  1981-07

4.  Immunochemical and immunohistochemical studies on three aldolase isozymes in human lung cancer.

Authors:  T Ojika; M Imaizumi; T Abe; K Kato
Journal:  Cancer       Date:  1991-04-15       Impact factor: 6.860

5.  Glycolysis as primary energy source in tumor cell chemotaxis.

Authors:  M E Beckner; M L Stracke; L A Liotta; E Schiffmann
Journal:  J Natl Cancer Inst       Date:  1990-12-05       Impact factor: 13.506

6.  Expression of aldolase C isozyme in renal cell carcinoma.

Authors:  M Takashi; H Haimoto; T Koshikawa; K Kato
Journal:  Am J Clin Pathol       Date:  1990-05       Impact factor: 2.493

7.  Detachment of glycolytic enzymes from cytoskeleton of Lewis lung carcinoma and colon adenocarcinoma cells induced by clotrimazole and its correlation to cell viability and morphology.

Authors:  Julia Penso; Rivka Beitner
Journal:  Mol Genet Metab       Date:  2002-07       Impact factor: 4.797

8.  Clotrimazole decreases glycolysis and the viability of lung carcinoma and colon adenocarcinoma cells.

Authors:  Julia Penso; Rivka Beitner
Journal:  Eur J Pharmacol       Date:  2002-09-20       Impact factor: 4.432

9.  Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium.

Authors:  Q Jackie Cao; Thomas Belbin; Nicholas Socci; Raluca Balan; Michael B Prystowsky; Geoffrey Childs; Joan G Jones
Journal:  Int J Gynecol Pathol       Date:  2004-10       Impact factor: 2.762

10.  Enzymes of glucose metabolism in carcinoma of the cervix and endometrium of the human uterus.

Authors:  M J Marshall; D M Goldberg; F E Neal; D R Millar
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  10 in total
  5 in total

1.  Significance of Anti-retinal Autoantibodies in Cancer-associated Retinopathy with Gynecological Cancers.

Authors:  Grazyna Adamus; Dongseak Choi; Anitha Raghunath; Jade Schiffman
Journal:  J Clin Exp Ophthalmol       Date:  2013-12-01

2.  Proteomics analysis of protein biomarkers in Astragalus membranaceus- and Astragaloside IV-treated brain tissues in ischemia-reperfusion injured rats.

Authors:  Wan-Yu Lo; Chung-Hsiang Liu; Chao-Hsiang Chen; Ching-Liang Hsieh
Journal:  J Tradit Complement Med       Date:  2021-05-05

3.  The role of hypoxic-inducible factor (HIF1α) and aldolaseC protein in endometrial carcinogenesis: a retrospective study of 279 patients.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Damanzoopinder Samrao; Teodulo Menesses; Heidi Godoy; Faith Ough; Shashikant Lele; Song Liu; Tanja Pejovic
Journal:  BMJ Open       Date:  2012-08-24       Impact factor: 2.692

4.  The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma.

Authors:  Juan Wang; Lihua Jia; Zirong Kuang; Tong Wu; Yun Hong; Xiaobing Chen; W Keung Leung; Juan Xia; Bin Cheng
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

5.  Aldolase positively regulates of the canonical Wnt signaling pathway.

Authors:  Michal Caspi; Gili Perry; Nir Skalka; Shilhav Meisel; Anastasia Firsow; Maayan Amit; Rina Rosin-Arbesfeld
Journal:  Mol Cancer       Date:  2014-07-04       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.